echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Neurology: stroke onset, lateral branch score, and functional outcomes after intravascular therapy for acute ischemic stroke

    Neurology: stroke onset, lateral branch score, and functional outcomes after intravascular therapy for acute ischemic stroke

    • Last Update: 2022-10-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    In patients with ischemic stroke who receive intravascular therapy (EVT), treatment time and collateral status are important prognostic factors and may be correlated


    The researchers analyzed data from 2014 to 2017 for patients with acute ischemic stroke included in the MR CLEAN register who had carotid artery terminal or M1 occlusion and were treated with EVT within 6.


    Conclusion: At the end of the carotid artery or the first 6.


    Sources: Uniken Venema SM, Wolff L, van den Berg SA, et al.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.